Advertisement
Organisation › Details
Bio-Techne Corporation (Nasdaq: TECH)
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotech Division, headquartered in Minneapolis, Minnesota. The Protein Platform Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls for OEM customer and clinical customers. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499 million in net sales in fiscal 2016 and has approximately 1,700 employees worldwide. *
Start | 2014-11-01 renamed | |
Group | Bio-Techne (Group) | |
Predecessor | Techne Corporation (Nasdaq: TECH) (d/b/a Bio-Techne) | |
Industry | diagnostics (medical/biological) | |
Industry 2 | reagents (bio/biochemical) | |
Person | Kummeth, Charles R. (Chuck) (Techne Corp 201304– CEO before Thermo Fisher 201204 Pres Chromatography + MS + 3M Medical) | |
Region | Minneapolis, MN | |
Country | United States (USA) | |
City | n. a. Minneapolis, MN | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2022-06-30) |
Currency | USD | |
Annual sales | 1,105,599,000 (net sales (2022FY) 2022-06-30) | |
Profit | 263,099,000 (2022-06-30) | |
Cash | 172,567,000 (2022-06-30) | |
* Document for »About Section«: | ||
Record changed: 2023-08-20 |
Advertisement
More documents for Bio-Techne (Group)
- [1] Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN....
- [2] Lunaphore Technologies S.A.. (4/17/23). "Press Release: Bio-Techne and Lunaphore Establish Strategic Partnership to Develop the First Fully Automated Same-slide Spatial Multiomics Solution". Minneapolis, MN & Lausanne....
- [3] |transkript [gkä, Kääb, Georg]. (10/26/21). "News: Aus für Exosome Diagnostics in Martinsried"....
- [4] Lunaphore Technologies S.A.. (5/13/21). "Press Release: Lunaphore Announces Appointment of Matthias Weber, former President of Leica Biosystems, to Board of Directors". Lausanne....
- [5] Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top